Kombiglyze XR

AstraZeneca Pharmaceuticals, LP🇵🇭 Food and Drug Administration - Philippines

Approval Id: a7da62c114707af6
Drug Approval Philippines Name: Kombiglyze XR
Product Name: Kombiglyze XR
Registration Number: DR-XY40720
Brand Name: Kombiglyze XR
Generic Name: Saxagliptin (as Hydrochloride) + Metformin Hydrochloride (in extended release form)
Dosage Form: Film-Coated Tablet
Dosage Strength: 2.5mg/ 1g
Manufacturer: AstraZeneca Pharmaceuticals, LP
Trader: AstraZeneca UK Limited
Importer: AstraZeneca Pharmaceuticals (Phils.), Inc.
Trader Detail Path: /organization/astrazeneca-uk-limited
Issuance Date: 28 December 2021
Expiry Date: 05 March 2027
Pharmacologic Category: Combination of Oral Blood Glucose Lowering Drugs
Classification: Prescription Drug (Rx)

Approved

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

a7da62c114707af6

Type

Standard